Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | Switzerland | Healthcare | Pharmaceuticals | CHF 625.70B | 86.7x | 1.31 | CHF 750 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Switzerland | Industrials | Construction & Engineering | CHF 946.84M | 17.5x | 2.3 | CHF 89 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.4% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Financial | Investment Banking & Investment Services | CHF 31.08B | 32.2x | -2.26 | CHF 1,185 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.5% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | CHF 7.11B | 47.7x | 2.67 | CHF 576.50 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.5% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Financial | Investment Banking & Investment Services | CHF 4.44B | 17.4x | 0.47 | CHF 300 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.6% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Consumer Cyclicals | Homebuilding & Construction Supplies | CHF 17.64B | 29.5x | -2.84 | CHF 536.60 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Switzerland | Consumer Cyclicals | Homebuilding & Construction Supplies | CHF 17.64B | 29.5x | -2.84 | CHF 533 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.7% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Healthcare | Pharmaceuticals | CHF 217.05B | 22.3x | -6.38 | CHF 272.30 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.9% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Healthcare | Pharmaceuticals | CHF 236.97B | 20.5x | -6.38 | CHF 296.40 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4% Downside | Upgrade to Pro+ |